MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

Search

Globus Medical Inc (Class A)

Закрыт

СекторЗдравоохранение

72.61 -0.64

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

72.58

Макс.

72.96

Ключевые показатели

By Trading Economics

Доход

-25M

27M

Продажи

32M

657M

P/E

Средняя по отрасли

92.52

57.333

Прибыль на акцию

0.84

Рентабельность продаж

4.032

Сотрудники

5,300

EBITDA

29M

145M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+34.73% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

8 мая 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-3.1B

9.5B

Предыдущая цена открытия

73.25

Предыдущая цена закрытия

72.61

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Globus Medical Inc (Class A) График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

27 апр. 2025 г., 23:55 UTC

Обсуждения рынка

Oil Edges Higher Amid Hopes for Easing U.S.-China Trade Tensions -- Market Talk

27 апр. 2025 г., 23:47 UTC

Обсуждения рынка

Gold Falls Amid Dollar Strength, Signs of Easing U.S.-China Trade Tensions -- Market Talk

27 апр. 2025 г., 23:42 UTC

Обсуждения рынка

Nikkei May Rise as Fears About U.S.-China Tensions Ebb -- Market Talk

27 апр. 2025 г., 23:12 UTC

Отчет

Sinopharm Group 1Q Rev CNY141.66B Vs. CNY147.27B >1099.HK

27 апр. 2025 г., 23:12 UTC

Отчет

Sinopharm Group 1Q Net CNY1.46B Vs. Net CNY1.42B >1099.HK

27 апр. 2025 г., 20:41 UTC

Отчет

Pharmaron Beijing 1Q Net CNY305.58M Vs. Net CNY230.56M >300759.SZ

27 апр. 2025 г., 20:41 UTC

Отчет

Pharmaron Beijing: Higher Contributions From Laboratory Services Among Factors Supporting Results> 300759.SZ

27 апр. 2025 г., 20:41 UTC

Отчет

Pharmaron Beijing 1Q Rev CNY3.10B Vs. CNY2.67B >300759.SZ

27 апр. 2025 г., 18:41 UTC

Главные новости

Bessent Doesn't Know If Trump and Xi Have Talked on Trade -- Barrons.com

27 апр. 2025 г., 11:00 UTC

Главные новости

Wall Street's New Tariff Safe Haven: High-Tax Biotech Stocks -- Heard on the Street -- WSJ

27 апр. 2025 г., 05:41 UTC

Отчет

China Everbright Bank 1Q Net CNY12.46B Vs. Net CNY12.43B >601818.SH

27 апр. 2025 г., 05:41 UTC

Отчет

China Everbright Bank: Lower Net Interest Income Weighed on Operating Income>601818.SH

27 апр. 2025 г., 05:41 UTC

Отчет

China Everbright Bank 1Q Operating Income CNY33.10B Vs. CNY34.49B>601818.SH

27 апр. 2025 г., 05:41 UTC

Отчет

China Everbright Bank 1Q Impairment Loss on Credit Assets Was CNY8.49B; Down 15.6% on Year>601818.SH

27 апр. 2025 г., 05:41 UTC

Отчет

China Everbright Bank 1Q Operating Expenses Was CNY9.15B; Down 3.2%>601818.SH

27 апр. 2025 г., 05:41 UTC

Отчет

China Everbright Bank 1Q Net Interst Income Was CNY22.54B; Down 6.8% on Year>601818.SH

27 апр. 2025 г., 05:34 UTC

Отчет

Chongqing Rural Commercial Bank: 1Q Results Supported by Higher Net Interest Income>3618.HK

27 апр. 2025 г., 05:34 UTC

Отчет

Chongqing Rural Commercial Bank 1Q Operating Income CNY7.22B Vs. CNY7.13B>3618.HK

27 апр. 2025 г., 05:34 UTC

Отчет

Chongqing Rural Commercial Bank 1Q Net CNY3.75B Vs. Net CNY3.52B >3618.HK

27 апр. 2025 г., 05:29 UTC

Отчет

China Shenhua Energy: Results Weighed by Fall in Selling Prices of Coal >1088.HK

27 апр. 2025 г., 05:29 UTC

Отчет

China Shenhua Energy 1Q Net CNY13.37B Vs. Net CNY17.76B >1088.HK

27 апр. 2025 г., 05:29 UTC

Отчет

China Shenhua Energy 1Q Rev CNY69.59B Vs. CNY87.65B >1088.HK

27 апр. 2025 г., 05:29 UTC

Отчет

China Shenhua Energy: Lower Revenue From Electricity Sales Also Hurt Results >1088.HK

27 апр. 2025 г., 05:21 UTC

Отчет

CMOC Group 1Q Net CNY3.95B Vs. Net CNY2.07B >3993.HK

27 апр. 2025 г., 05:21 UTC

Отчет

CMOC Group: Cost Cuts Also Among Factors that Boosted 1Q Net >3993.HK

27 апр. 2025 г., 05:21 UTC

Отчет

CMOC Group 1Q Rev CNY46.01B Vs. CNY46.12B >3993.HK

27 апр. 2025 г., 05:21 UTC

Отчет

CMOC Group: Increase in Prices of Copper, Cobalt Supported Results>3993.HK

27 апр. 2025 г., 03:00 UTC

Главные новости

Chinese Manufacturers Are Scouring the World for New Buyers -- WSJ

27 апр. 2025 г., 00:30 UTC

Главные новости

Meta's 'Digital Companions' Will Talk Sex With Users -- Even Children -- WSJ

27 апр. 2025 г., 00:30 UTC

Главные новости

Meta's 'Digital Companions' Will Talk Sex With Users -- Even Children -- WSJ -2-

Сравнение c конкурентами

Изменение цены

Globus Medical Inc (Class A) Прогноз

Целевая цена

By TipRanks

34.73% рост

Прогноз на 12 месяцев

Средняя 98.08 USD  34.73%

Максимум 115 USD

Минимум 80 USD

Основано на мнении 14 аналитиков Wall Street, спрогнозировавших целевые цены для Globus Medical Inc (Class A) на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

14 ratings

10

Покупка

4

Удержание

0

Продажа

Техническая оценка

By Trading Central

71.68 / 73.45Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bearish Evidence

Долгосрочная

Weak Bearish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.